-
GENALICE prepares for launch of raw DNA sequence data processing software – Management Team Realignment
Friday 10 May 2013
GENALICE B.V., specialized in designing and developing innovative software solutions for DNA analysis, correlation and processing of biomedical Big Data, today announced the imminent release of the beta version of its first product, GENALICE MAP, to take place within the next few weeks.
» Continue reading -
GENALICE presents breakthrough test results for GENALICE MAP at NBIC 2013
Friday 10 May 2013
GENALICE presents breakthrough test results for GENALICE MAP at the Netherlands Bioinformatics Conference (NBIC 2013).
» Continue reading -
Featured article about GENALICE in Financieele Dagblad (in Dutch)
Friday 10 May 2013
(Source: Financieele Dagblad, March 9, 2013: “‘Big Data’ gaat medici helpen in de strijd tegen kanker” by Hans de Jongh)
-
GENALICE wins VentureLab award
Thursday 20 September 2012
Bert Reijmerink, CEO of GENALICE, is the winner of the VentureLab Twente Growth Award. The award will be granted today at 7.45 PM at Venture Lab Twente, Corridor building.
With this Growth Award – a silver pin- VentureLab emphasizes the growth potential of promising participants in her growth program for high-tech companies. The Growth Award is the second prize that high-tech company GENALICE receives this year, after being granted the national ICT Award in June 2012.
» Continue reading -
DNA Research Accelerated by New Alignment Software
Tuesday 11 September 2012
Today GENALICE will present the findings of its latest product prototype at the European Conference on Computational Biology (ECCB12). In a direct comparison with three of the current standards, the new software tool of GENALICE performs DNA alignment much faster and more accurately. A breakthrough, as this makes research into DNA diseases, such as cancer, faster, better and cheaper.
